For the first time, researchers from Beth Israel Deaconess Medical Center (BIDMC) have identified two clusters of depressive symptoms that respond to two distinct treatment targets in patients undergoing transcranial magnetic brain stimulation (TMS).
TMS is a non-invasive procedure that affects brain activity with powerful magnetic fields. The findings, published in the American Journal of Psychiatry, shed new light on the brain circuitry behind specific symptoms of depression and may pave the way for personalized TMS therapy for depression and other psychiatric or neurological disorders.
Specifically, the analysis identified two distinct clusters of depressive symptoms, with each responding better to a different TMS target.
Read more on psychcentral.com